73092 Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices 

4. Australian Patent 2009231978, 

issued February 20, 2014, titled ‘‘Purine 

Derivatives As A3 Adenosine ReceptorSelective Agonists’’ [HHS Ref. No. E– 

140–2008/0–AU–03]; 

5. U.S. Patent Application 13/371,081, 

filed February 10, 2012, titled ‘‘A3 

Adenosine Receptor Agonists And 

Antagonists’’ [HHS Ref. No. E–140– 

2008/1–US–01]; 

6. U.S. Provisional Application 61/ 

909,742, filed November 27, 2013, titled 

‘‘A3 Adenosine Receptor Agonists’’ 

[HHS Ref. No. E–742–2013/0–US–01]; 

and 

7. U.S. Provisional Application 62/ 

033,723, filed August 6, 2014, titled ‘‘A3 

Adenosine Receptor Agonists’’ [HHS 

Ref. No. E–210–2014/0–US–01]. 

The patent rights in these inventions 

either have been assigned to the 

Government of the United States of 

America, or have been granted exclusive 

rights to the Government of the United 

States of America. The territory of the 

prospective Start-up Exclusive 

Evaluation Option License Agreement 

may be worldwide, and the field of use 

may be limited to: ‘‘The use of an A3 

Adenosine Receptor (A3AR) agonist as 

an orally-administered analgesic, either 

as monotherapy or as an add-on 

analgesic, for treatment of chronic 

neuropathic pain conditions’’. 

Upon the expiration or termination of 

the Start-up Exclusive Evaluation 

Option License Agreement, 

BioIntervene will have the exclusive 

right to execute a Start-up Exclusive 

Patent License Agreement which will 

supersede and replace the Start-up 

Exclusive Evaluation Option License 

Agreement, with no greater field of use 

and territory than granted in the Startup Exclusive Evaluation Option License 

Agreement. 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before 

December 24, 2014 will be considered. 

ADDRESSES: Requests for copies of the 

patents, patent applications, inquiries, 

comments, and other materials relating 

to the contemplated Start-Up Exclusive 

Evaluation Option License Agreement 

should be directed to: Betty B. Tong, 

Ph.D., Senior Licensing and Patenting 

Manager, Office of Technology Transfer, 

National Institutes of Health, 6011 

Executive Boulevard, Suite 325, 

Rockville, MD 20852–3804; Telephone: 

(301) 594–6565; Facsimile: (301) 402– 

0220; Email: tongb@mail.nih.gov. A 

signed confidentiality nondisclosure 

agreement will be required to receive 

copies of any patent applications that 

have not been published or issued by 

the United States Patent and Trademark 

Office or the World Intellectual Property 

Organization. 

SUPPLEMENTARY INFORMATION: The 

subject inventions describe selective A3 

Adenosine Receptor (A3AR) agonists, 

and their in vivo activity reducing or 

preventing development of chronic 

neuropathic pain in an animal model. 

The A3AR subtype was linked with 

helping protect the heart from ischemia, 

controlling inflammation, and 

regulating cell proliferation. The 

compounds claimed are consistently 

highly selective and have smaller 

molecular weight, thus can offer greater 

oral bioavailability. Hence, the subject 

inventions may provide a new treatment 

for chronic neuropathic pain. 

The prospective Start-up Exclusive 

Evaluation Option License Agreement 

and a subsequent Start-up Exclusive 

Patent License Agreement may be 

granted unless the NIH receives written 

evidence and argument, within fifteen 

(15) days from the date of this published 

notice, that establishes that the grant of 

the contemplated Start-up Exclusive 

Evaluation Option License Agreement 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR part 404. 

Complete applications for a license in 

the prospective field of use that are filed 

in response to this notice will be treated 

as objections to the grant of the 

contemplated Start-Up Exclusive 

Evaluation Option License Agreement. 

Comments and objections submitted in 

response to this notice will not be made 

available for public inspection and, to 

the extent permitted by law, will not be 

released under the Freedom of 

Information Act, 5 U.S.C. 552. 

Dated: December 3, 2014. 

Richard U. Rodriguez, 

Acting Director, Office of Technology 

Transfer, National Institutes of Health. 

[FR Doc. 2014–28749 Filed 12–8–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

[OMB Control Number 1615–0030] 

Agency Information Collection 

Activities: Application for Waiver of the 

Foreign Residence Requirement of 

Section 212(e) of the Immigration and 

Nationality Act, Form I–612; Revision 

of a Currently Approved 

ACTION: 30-Day Notice. 

SUMMARY: The Department of Homeland 

Security (DHS), U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The information collection notice 

was previously published in the Federal 

Register on September 10, 2014, at 79 

FR 53720, allowing for a 60-day public 

comment period. USCIS did receive 1 

comment in connection with the 60-day 

notice. 

DATES: The purpose of this notice is to 

allow an additional 30 days for public 

comments. Comments are encouraged 

and will be accepted until January 8, 

2015. This process is conducted in 

accordance with 5 CFR 1320.10. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, must be 

directed to the OMB USCIS Desk Officer 

via email at oira_submission@

omb.eop.gov. Comments may also be 

submitted via fax at (202) 395–5806. All 

submissions received must include the 

agency name and the OMB Control 

Number 1615–0030. 

You may wish to consider limiting the 

amount of personal information that you 

provide in any voluntary submission 

you make. For additional information 

please read the Privacy Act notice that 

is available via the link in the footer of 

http://www.regulations.gov. 

SUPPLEMENTARY INFORMATION: 

Comments: 

Note: The address listed in this notice 

should only be used to submit 

comments concerning this information 

collection. Please do not submit 

requests for individual case status 

inquiries to this address. If you are 

seeking information about the status of 

your individual case, please check ‘‘My 

Case Status’’ online at: https://

egov.uscis.gov/cris/Dashboard.do, or 

call the USCIS National Customer 

Service Center at 1–800–375–5283. 

Written comments and suggestions 

from the public and affected agencies 

should address one or more of the 

following four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 


rljohnson on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices 73093 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection 

Request: Revision of a Currently 

Approved Collection. 

(2) Title of the Form/Collection: 

Application for Waiver of the Foreign 

Residence Requirement of Section 

212(e) of the Immigration and 

Nationality Act. 

(3) Agency form number, if any, and 

the applicable component of the DHS 

sponsoring the collection: I–612; USCIS. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Individuals or 

households. This information collection 

is necessary and may be submitted only 

by an alien who believes that 

compliance with foreign residence 

requirements would impose exceptional 

hardship on his or her spouse or child 

who is a citizen of the United States, or 

a lawful permanent resident; or that 

returning to the country of his or her 

nationality or last permanent residence 

would subject him or her to persecution 

on account of race, religion, or political 

opinion. Certain aliens admitted to the 

United States as exchange visitors are 

subject to the foreign residence 

requirements of section 212(e) of the 

Immigration and Nationality Act (the 

Act). Section 212(e) of the Act also 

provides for a waiver of the foreign 

residence requirements in certain 

instances. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: The estimated total number of 

respondents for the information 

collection I–612 is 1,300 and the 

estimated hour burden per response is 

.333 hours. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: The total estimated annual 

hour burden associated with this 

collection is 433 hours. 

If you need a copy of the information 

collection instrument with 

supplementary documents, or need 

additional information, please visit 

http://www.regulations.gov. We may 

also be contacted at: USCIS, Office of 

Policy and Strategy, Regulatory 

Coordination Division, 20 

Massachusetts Avenue NW, 

Washington, DC 20529–2134; 

Telephone 202–272–8377. 

Dated: December 3, 2014. 

Laura Dawkins, 

Chief, Regulatory Coordination Division, 

Office of Policy and Strategy, U.S. Citizenship 

and Immigration Services, Department of 

Homeland Security. 

[FR Doc. 2014–28781 Filed 12–8–14; 8:45 am] 

BILLING CODE 9111–97–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Citizenship and Immigration 

Services 

[OMB Control Number 1615–0063] 

Agency Information Collection 

Activities: National Interest Waivers, 

Supplemental Evidence to I–140 and I– 

485, No Agency Form Number; 

Extension, Without Change, of a 

Currently Approved Collection 

ACTION: 30-day Notice. 

* * * * * 

SUMMARY: The Department of Homeland 

Security (DHS), U.S. Citizenship and 

Immigration Services (USCIS) will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and clearance in accordance 

with the Paperwork Reduction Act of 

1995. The information collection notice 

was previously published in the Federal 

Register on August 8, 2014, at 79 FR 

46447, allowing for a 60-day public 

comment period. USCIS did not receive 

any comments in connection with the 

60-day notice. 

DATES: The purpose of this notice is to 

allow an additional 30 days for public 

comments. Comments are encouraged 

and will be accepted until January 8, 

2015. This process is conducted in 

accordance with 5 CFR 1320.10. 

ADDRESSES: Written comments and/or 

suggestions regarding the item(s) 

contained in this notice, especially 

regarding the estimated public burden 

and associated response time, must be 

directed to the OMB USCIS Desk Officer 

via email at oira_submission@

omb.eop.gov. Comments may also be 

submitted via fax at (202) 395–5806. All 

submissions received must include the 

agency name and the OMB Control 

Number 1615–0063. 

You may wish to consider limiting the 

amount of personal information that you 

provide in any voluntary submission 

you make. For additional information 

please read the Privacy Act notice that 

is available via the link in the footer of 

http://www.regulations.gov. 

SUPPLEMENTARY INFORMATION: 

Comments 

Note: The address listed in this notice 

should only be used to submit comments 

concerning this information collection. 

Please do not submit requests for individual 

case status inquiries to this address. If you 

are seeking information about the status of 

your individual case, please check ‘‘My Case 

Status’’ online at: https://egov.uscis.gov/cris/ 

Dashboard.do, or call the USCIS National 

Customer Service Center at 1–800–375–5283. 

Written comments and suggestions 

from the public and affected agencies 

should address one or more of the 

following four points: 

(1) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(2) Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

(4) Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses. 

Overview of this Information Collection 

(1) Type of Information Collection 

Request: Extension, Without Change, of 

a Currently Approved Collection. 

(2) Title of the Form/Collection: 

National Interest Waivers, Supplemental 

Evidence to I–140 and I–485. 

(3) Agency form number, if any, and 

the applicable component of the DHS 

sponsoring the collection: No Agency 

Form Number; USCIS. 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: Individuals or 

households. The supplemental 

documentation will be used by the U.S. 

Citizenship and Immigration Services to 

determine eligibility for national 

interest waiver requests for physicians 

and to finalize the request for 

adjustment to lawful permanent 

resident status. 


rljohnson on DSK3VPTVN1PROD with NOTICES